• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER SEPTAL OCCLUDER; CARDIAC OCCLUSION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER SEPTAL OCCLUDER; CARDIAC OCCLUSION DEVICE Back to Search Results
Model Number 9-ASD-019
Device Problems Obstruction of Flow (2423); Device Contamination with Chemical or Other Material (2944)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 06/12/2014
Event Type  Injury  
Event Description
A 19mm amplatzer septal occluder (aso) was selected for use.After release from the delivery cable, the aso embolized into the left atrium.The aso was percutaneously snared through a 12f amplatzer torqvue 45 system which was cut at an angle at the tip to retract the aso into the sheath more smoothly.After the aso was removed from the patient a marker band-like material was found in the left atrial appendage as confirmed by tee and angiography.The patient underwent open heart surgery where the marker band-like material was removed and the atrial septal defect was closed with a pericardial patch.The patient was stable after the surgery.
 
Manufacturer Narrative
The 19mm aso was received at sjm and decontaminated.The aso was grossly and microscopically examined, and no anomalies were found.It met dimensional specifications when measured with a caliper.The aso was loaded into a test 8f loader, deployed and retracted without difficulty or deformation, under non-physiological conditions.The device history record for this product was reviewed to ensure that each manufacturing and inspection operation was performed.The review determined the process was performed and completed in accordance with sjm specifications and procedures.
 
Event Description
Reference 2135147-2014-00063 for the amplatzer delivery system.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER SEPTAL OCCLUDER
Type of Device
CARDIAC OCCLUSION DEVICE
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer Contact
denise johnson
5050 nathan lane north
plymouth, MN 55442
6517565400
MDR Report Key3918230
MDR Text Key18575334
Report Number2135147-2014-00062
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P000039
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 06/12/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/08/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/31/2018
Device Model Number9-ASD-019
Device Catalogue Number9-ASD-019
Device Lot Number4178602
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/01/2014
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/09/2014
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/01/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
SNARE; 9-ITV12F45/80, LOT 4595860
Patient Outcome(s) Required Intervention;
Patient Age7 YR
-
-